Cholangiocarcinomas Suspended Phase 2 Trials for Trifluridine (DB00432)

Also known as: Cholangiocarcinoma / Cholangiocarcinoma NOS / Cholangiocarcinoma of biliary tract

IndicationStatusPhase
DBCOND0051818 (Cholangiocarcinomas)Suspended2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03278106TAS-102 in Treating Advanced Biliary Tract CancersTreatment